Please assess the completion status of the following clinical trial:

Trial Title: Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inactive UC~* Age 16-75 years~* Minimum 1 year on Azathioprine or Mercaptopurine.~* Simple Colitis Activity Index (SCCAI) score \<3~* Baron's sigmoidoscopic score \<2 .~* In remission for at least 3 months~* No change to other maintenance therapy (including 5ASA) for at least 4 months~Exclusion Criteria:~* Use of prednisolone orally or topically, or of topical 5ASA for at least 3 months Antibiotics, warfarin, anti-diarrhoeal drugs, non-steroidal anti-inflammatory drugs (NSAIDs), aspirin \> 75 mg/day~* Herbal remedies~* Alcohol or drug abuse~* Pregnancy or breast feeding~* Female of child-bearing age not taking adequate contraception~* Participation in another drug trial in the previous three months~* Serious liver, renal, cardiac, respiratory, endocrine, neurological or psychiatric illness~* Already use relaxation techniques or computerized feedback

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Gut-focussed hypnotherapy (GFH). (Type: ACTIVE_COMPARATOR): Gut-focussed hypnotherapy (GFH).
- Educational sessions (Type: SHAM_COMPARATOR): Regular sessions to learn about UC from research nurse

Based on this trial design, predict the completion outcome and termination type (if applicable).